Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Tamiflu 5-day versus 10-day treatment in 2009 H1N1 influenza
ACTRN12610000361000Phase 4Recruiting
- Sponsor
- Roche
- Start
- Aug 2009
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, randomised trial of oseltamivir in influenza A(H1N1)2009 (H1N1) (2 arms), sponsored by Roche. Primary endpoint: Difference in proportion of patients shedding virus and proportion exhibiting resistance by treatment duration. Started Aug 2009; status: recruiting.
02
Drugs
oseltamivir
03
Conditions
influenza A(H1N1)2009 (H1N1)
Beyond the preview
Go deeper on ACTRN12610000361000.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ACTRN12610000361000.